
浏览全部资源
扫码关注微信
1.西南医科大学药学院,四川 泸州 646000
2.西南医科大学附属医院药学部,四川 泸州 646000
硕士研究生。研究方向:天然药物活性与中药药理。E-mail:renqiangchen@126.com
教授,硕士生导师,博士。研究方向:分子生药学与中药药理。E-mail:zc83good@126.com
收稿:2022-03-25,
修回:2022-08-23,
纸质出版:2022-10-30
移动端阅览
陈仁强,刘桢,胡慧玲,等.紫花地丁总香豆素提取工艺优化及其抗氧化和抗肿瘤活性考察[J].中国药房,2022,33(20):2471-2476.
CHEN Renqiang,LIU Zhen,HU Huiling,et al.Optimization of the extraction technology of total coumarin from Viola yedoensis and its antioxidant and anti-tumor activities[J].ZHONGGUO YAOFANG,2022,33(20):2471-2476.
陈仁强,刘桢,胡慧玲,等.紫花地丁总香豆素提取工艺优化及其抗氧化和抗肿瘤活性考察[J].中国药房,2022,33(20):2471-2476. DOI: 10.6039/j.issn.1001-0408.2022.20.08.
CHEN Renqiang,LIU Zhen,HU Huiling,et al.Optimization of the extraction technology of total coumarin from Viola yedoensis and its antioxidant and anti-tumor activities[J].ZHONGGUO YAOFANG,2022,33(20):2471-2476. DOI: 10.6039/j.issn.1001-0408.2022.20.08.
目的
2
优化紫花地丁总香豆素的提取工艺,并评价其纯化物的体外抗氧化活性和抗肿瘤活性。
方法
2
在单因素实验的基础上,以紫花地丁总香豆素得率为响应值,以液料比、提取时间、乙醇体积分数为变量,采用响应面法优化紫花地丁总香豆素的提取工艺并验证。采用1,1-二苯基-2-三硝基苯肼(DPPH)法、2,2′-联氮双(3-乙基苯并噻唑啉-6-磺酸)二铵盐(ABTS)法和2-苯基-4,4,5,5-四甲基咪唑啉-3-氧代-1-氧(PTIO)法评价紫花地丁总香豆素纯化物的抗氧化活性。采用CCK-8法检测其对人宫颈癌细胞HeLa、人胆管细胞型肝癌细胞HCCC-9810、人肝癌细胞HepG2、人乳腺癌细胞MDA-MB-231和人非小细胞肺癌细胞A549的抑制作用;采用Hoechst 33258染色法检测其对HCCC-9810细胞凋亡形态的影响,并测定细胞中乳酸脱氢酶(LDH)和超氧化物歧化酶(SOD)含量。
结果
2
最优提取工艺为液料比25∶1(mL/g)、提取时间1.9 h、乙醇体积分数68%;3次验证实验的紫花地丁总香豆素平均得率为(21.10±0.17)mg/g,RSD为0.80%(
n
=3),与预测值(20.79 mg/g)的相对误差为1.49%。紫花地丁总香豆素纯化物对DPPH和ABTS自由基的半数抑制浓度(IC
50
)分别为21.54、17.11 μg/mL,略高于抗坏血酸的15.21、12.45 μg/mL;对PTIO自由基的IC
50
为1 422.01 μg/mL,远高于抗坏血酸的37.20 μg/mL;对上述5种细胞的IC
50
分别为(113.18±15.97)、(51.17±1.72)、(134.15±11.75)、(171.83±15.27)、(93.38±4.65)μg/mL;能促进HCCC-9810细胞凋亡,增加其LDH含量并降低SOD含量。
结论
2
成功优化了紫花地丁总香豆素的提取工艺;所得提取物的纯化物具有抗氧化活性和抗肿瘤活性。
OBJECTIVE
2
To optimize the extraction technology of total coumarin from
Viola yedoensis
and to evaluate its
in vitro
antioxidant and anti-tumor activities of its purified product.
METHODS
2
On the basis of single factor experiments, the extraction technology of total coumarin from
V. yedoensis
was optimized by the response surface methodology, using yield of total coumarin from
V. yedoensis
as response value, solid-liquid ratio, extraction time and ethanol volume fraction as variables. The verification tests were conducted. The antioxidant activity of purified product of total coumarin from
V. yedoensis
was evaluated by 1,1-diphenyl-2-picrylhydrazyl (DPPH) method, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic) acid ammonium salt (ABTS) method and 2-phenyl-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl (PTIO) method. CCK-8 assay was used to determine the inhibitory effect of it on human cervical cancer cells HeLa, human intrahepatic bile duct cancer cells HCCC-9810, human hepatocellular carcinoma cells HepG2, human breast cancer cells MDA-MB-231 and human non-small cell lung cancer cells A549. The apoptosis morphology of HCCC-9810 cells was detected by Hoechst 33258 staining, and lactate dehydrogenase (LDH) and superoxide dismutase (SOD) content were determined.
RESULTS
2
The optimal extraction technology included solid-liquid ratio was 25∶1 (mL/g), extraction time was 1.9 h, ethanol volume fraction was 68%. Average yield of total coumarin from
V. yedoensis
was (21.10±0.17) mg/g, and RSD was 0.80%(
n
=3), relative error of which with predicted value (20.79 mg/g) was 1.49%. The median inhibitory concentrations (IC
50
) of purified product of total coumarin from
V. yedoensis
to DPPH and ABTS free radicals were 21.54 and 17.11 μg/mL, which were slightly higher than that of ascorbic acid (15.21, 12.45 μg/mL). The IC
50
to PTIO free radicals was 1 422.01 μg/mL, which was far higher the that of ascorbic acid (37.20 μg/mL). The IC
50
values of total coumarin from
V. yedoensis
to above 5 cells were (113.18±15.97), (51.17±1.72), (134.15±11.75),(171.83±15.27) and (93.38±4.65)μg/mL, respectively. Total coumarin from
V. yedoensis
induced the apoptosis of HCCC-9810 cells and increased the content of LDH, as well as decreased the content of SOD.
CONCLUSIONS
2
The extraction technology of total coumarin from
V. yedoensis
is optimized successfully; the purified product of obtained extract has good antioxidant and anti-tumor activities.
国家药典委员会 . 中华人民共和国药典:一部 [S ] . 2020年版. 北京 : 中国医药科技出版社 , 2020 : 352 .
李永生 , 何希瑞 , 杨燕 , 等 . 紫花地丁化学成分与药理活性研究新进展 [J ] . 环球中医药 , 2013 , 6 ( 4 ): 313 - 318 .
HUANG S F , CHU S C , HSIEH Y H , et al . Viola yedoensis suppresses cell invasion by targeting the protease and NF-κB activities in A549 and lewis lung carcinoma cells [J ] . Int J Med Sci , 2018 , 15 ( 4 ): 280 - 290 .
袁会成 , 赵良存 , 万学娜 , 等 . 紫花地丁多糖对A549细胞增殖抑制机理的研究 [J ] . 热带医学杂志 , 2020 , 20 ( 8 ): 1005 - 1008 .
张琳 , 陈雅思 . 紫花地丁总黄酮的抗氧化作用研究 [J ] . 粮食与食品工业 , 2021 , 28 ( 1 ): 55 - 58 .
郭鹏杰 , 林志健 , 张晓朦 , 等 . 香豆素类化合物毒理研究及安全性思考 [J ] . 中国中药杂志 , 2020 , 45 ( 3 ): 518 - 522 .
OSHIMA N , NARUKAWA Y , TAKEDA T , et al . Collagenase inhibitors from Viola yedoensis [J ] . J Nat Med , 2013 , 67 ( 1 ): 240 - 245 .
国家药典委员会 . 中华人民共和国药典:四部 [S ] . 2020年版. 北京 : 中国医药科技出版社 , 2020 : 480 - 483 .
冯倩 , 郑伟 , 关永霞 , 等 . 紫花地丁中秦皮乙素、总香豆素大孔树脂纯化工艺研究 [J ] . 现代中药研究与实践 , 2020 , 34 ( 4 ): 39 - 43 .
李欣坪 , 王蒙蒙 , 王子晨 , 等 . 滇黄芩茎叶乙醇提取物及其不同溶剂萃取部位的抗氧化和降脂活性研究 [J ] . 中国药房 , 2021 , 32 ( 2 ): 220 - 225 .
李原 , 赵振刚 . 凤眼果壳多酚的抗氧化和抗人肺癌细胞A549增殖活性 [J ] . 现代食品科技 , 2021 , 37 ( 4 ): 16 - 24 .
王钦波 , 王晓东 . PTIO自由基清除分析法的pH值效应与黄芩素及黄芩苷的构效分析 [J ] . 现代医院 , 2019 , 19 ( 1 ): 145 - 148,153 .
彭梦媛 , 邱峰 , 黄丹 , 等 . 姜黄素对胰腺癌SW1990细胞耐吉西他滨的逆转作用及机制研究 [J ] . 中国药房 , 2019 , 30 ( 9 ): 1192 - 1197 .
陈建平 , 李琳 , 苏健裕 . 姜黄素的抗氧化及抗肿瘤活性研究 [J ] . 现代食品科技 , 2014 , 30 ( 12 ): 6,11 - 15 .
ELFERINK J G . Changes of plasma membrane permeabi-lity in neutrophils treated with polycations [J ] . Inflammation , 1991 , 15 ( 2 ): 103 - 115 .
BATINIC-HABERLE I , TOVMASYAN A , ROBERTS E R , et al . SOD therapeutics:latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways [J ] . Antioxid Redox Signal , 2014 , 20 ( 15 ): 2372 - 2415 .
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
公网安备50010302001817